4.0
Mar 26, 2011
Current employee
Recommend
CEO approval
Business Outlook
Pros
- Monopoly on BRCA mutation testing gives us total price control. - Fair amount of freedom in territory management. - Good customer service structure.
Cons
- Pay is pretty bad compared to other sales gigs. - Tremendous uncertainty associated with the BRAC patent and court battle - A LOT of senior leadership has recently come in from primary care pharma and they are totally clueless on how oncology works.